Investment Analysts’ Weekly Ratings Changes for Calian Group (CGY)

A number of firms have modified their ratings and price targets on shares of Calian Group (TSE: CGY) recently:

• 11/27/2025 – Calian Group had its price target raised by analysts at Desjardins from C$59.00 to C$66.00. They now have a “buy” rating on the stock.
• 11/27/2025 – Calian Group had its price target raised by analysts at Ventum Financial from C$58.00 to C$62.00. They now have a “buy” rating on the stock.
• 11/27/2025 – Calian Group had its price target raised by analysts at Canaccord Genuity Group Inc. from C$60.00 to C$63.00. They now have a “buy” rating on the stock.
• 11/27/2025 – Calian Group had its price target raised by analysts at Royal Bank Of Canada from C$58.00 to C$66.00. They now have an “outperform” rating on the stock.
• 10/29/2025 – Calian Group had its price target raised by analysts at CIBC from C$59.00 to C$62.00. They now have an “outperform” rating on the stock.

Calian Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 23rd. Investors of record on Tuesday, December 23rd will be issued a dividend of $0.28 per share. The ex-dividend date of this dividend is Tuesday, December 9th. This represents a $1.12 annualized dividend and a dividend yield of 1.9%. Calian Group’s dividend payout ratio (DPR) is currently 63.64%.

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.